Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 19441

1.
2.

Factors affecting compliance with colorectal cancer screening among households residing in the largely Haitian community of Little Haiti, Miami-Dade County, Florida: an observational study.

Wilcox ML, Acuña JM, de la Vega PR, Castro G, Madhivanan P.

Medicine (Baltimore). 2015 May;94(18):e806. doi: 10.1097/MD.0000000000000806.

PMID:
25950687
3.

TGFβ-1 and TGFBR2 polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese nonsmoking females: a case control study.

Ren Y, Yin Z, Li K, Wan Y, Li X, Wu W, Guan P, Zhou B.

BMC Med Genet. 2015 Apr 10;16:22. doi: 10.1186/s12881-015-0170-5.

4.
5.

Germline TP53 mutational spectrum in French Canadians with breast cancer.

Arcand SL, Akbari MR, Mes-Masson AM, Provencher D, Foulkes WD, Narod SA, Tonin PN.

BMC Med Genet. 2015 Apr 12;16:24. doi: 10.1186/s12881-015-0169-y.

6.

Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study.

Mok Y, Kimm H, Shin SY, Jee SH, Platz EA.

Urology. 2015 May;85(5):1111-6. doi: 10.1016/j.urology.2015.02.014.

PMID:
25917733
7.

Clinical characteristics and prognostic factors of gastroenteropancreatic neuroendocrine tumors: a single center experience in China.

Hu HK, Ke NW, Li A, Du XJ, Guo Q, Hu WM.

Hepatogastroenterology. 2015 Jan-Feb;62(137):178-83.

PMID:
25911892
8.

Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.

Wang B, Li X, Zhang X, Ma X, Chen L, Zhang Y, Lyu X, Tang Y, Huang Q, Gao Y, Fan Y, Ouyang J.

Medicine (Baltimore). 2015 Apr;94(16):e708. doi: 10.1097/MD.0000000000000708.

PMID:
25906099
9.

Gastrointestinal stromal tumors: treatment patterns of a population-based sample.

Harlan LC, Eisenstein J, Russell MC, Stevens JL, Cardona K.

J Surg Oncol. 2015 May;111(6):702-7. doi: 10.1002/jso.23879.

PMID:
25900896
10.

Identification of novel genetic markers of breast cancer survival.

Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Couch FJ, Olson JE, Vachon C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Broeks A, Hogervorst FB, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cox A, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Dieffenbach AK, Arndt V, Holleczek B, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Bonanni B, Mariani P, Fasching PA, Beckmann MW, Hein A, Ekici AB, Chenevix-Trench G, Balleine R; kConFab Investigators, Phillips KA, Benitez J, Zamora MP, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S, Evans DG, Abraham JE, Earl HM, Hiller L, Dunn JA, Bowden S, Berg C, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson SE, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, García-Closas M, Hall P, Easton DF, Eccles DM, Rahman N, Nevanlinna H, Pharoah PD.

J Natl Cancer Inst. 2015 Apr 18;107(5). pii: djv081. doi: 10.1093/jnci/djv081. Print 2015 May.

11.

Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer.

Fagan P, Moolchan ET, Pokhrel P, Herzog T, Cassel KD, Pagano I, Franke AA, Kaholokula JK, Sy A, Alexander LA, Trinidad DR, Sakuma KL, Johnson CA, Antonio A, Jorgensen D, Lynch T, Kawamoto C, Clanton MS; Addictive Carcinogens Workgroup.

Am J Public Health. 2015 Jun;105(6):1237-45. doi: 10.2105/AJPH.2014.302492. Epub 2015 Apr 16.

PMID:
25880962
12.

[Interaction between smoking and nicotine acetylcholine receptor subunits alpha 5 gene rs17486278 polymorphisms on lung cancer].

Li Q, Jiang M, Zhao S, Wu X, Zhou S, Liu T, Wang H, Zhang Y, Chen W.

Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Jan;36(1):67-70. Chinese.

PMID:
25876869
13.

Factors that influence minority use of high-volume hospitals for colorectal cancer care.

Huang LC, Tran TB, Ma Y, Ngo JV, Rhoads KF.

Dis Colon Rectum. 2015 May;58(5):526-32. doi: 10.1097/DCR.0000000000000353.

PMID:
25850840
14.

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Jagsi R, Griffith KA, Kurian AW, Morrow M, Hamilton AS, Graff JJ, Katz SJ, Hawley ST.

J Clin Oncol. 2015 May 10;33(14):1584-91. doi: 10.1200/JCO.2014.58.5885. Epub 2015 Apr 6.

PMID:
25847940
15.

Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010.

Eskandar A, Ahmed A, Daughtey M, Kenderian S, Mahdi F, Khan A.

Chest. 2015 Apr;147(4):e164-5. doi: 10.1378/chest.14-3051. No abstract available.

PMID:
25846546
16.

The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.

Guo S, Jiang X, Chen X, Chen L, Li X, Jia Y.

Gene. 2015 Jul 1;565(1):90-5. doi: 10.1016/j.gene.2015.03.067. Epub 2015 Apr 2.

PMID:
25841988
17.

Fluorine-18-fluoroethylcholine PET/CT in the detection of prostate cancer: a South African experience.

Vorster M, Modiselle M, Ebenhan T, Wagener C, Sello T, Zeevaart JR, Moshokwa E, Sathekge MM.

Hell J Nucl Med. 2015 Jan-Apr;18(1):53-9.

18.

New tool improves doctor-patient communication.

Fillon M.

J Natl Cancer Inst. 2015 Apr 2;107(4). pii: djv116. doi: 10.1093/jnci/djv116. Print 2015 Apr. No abstract available.

PMID:
25838445
19.

Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.

Liu Y, Xie L, Zhao J, Huang X, Song L, Luo J, Ma L, Li S, Qin X.

Medicine (Baltimore). 2015 Apr;94(13):e702. doi: 10.1097/MD.0000000000000702.

PMID:
25837767
20.

The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis.

Shen Y, Li D, Tian P, Shen K, Zhu J, Feng M, Wan C, Yang T, Chen L, Wen F.

Medicine (Baltimore). 2015 Apr;94(13):e679. doi: 10.1097/MD.0000000000000679. Review.

PMID:
25837760
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk